Detailed study of changes in renal function after conversion from cyclosporine to azathioprine

Clinical Nephrology

Volumn 45, Issue 4, 1996, Pages 230-235

  Hilbrands, L B ^a   Hoitsma, A J ^a   Wetzels, J F M ^a   Koene, R A P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Conversion; Cyclosporine; Renal function; Renal transplantation

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN; MAGNESIUM; URATE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG CLEARANCE; DRUG WITHDRAWAL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAGNESIUM BLOOD LEVEL; MALE; ORAL DRUG ADMINISTRATION; PROSPECTIVE STUDY;

ADULT; AZATHIOPRINE; CREATININE; CYCLOSPORINE; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MAGNESIUM; MALE; PROSPECTIVE STUDIES; TIME FACTORS; URIC ACID;

EID: 0029879499     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bantle JP, Nath KA, Sutherland DER, Najarian JS, Ferris TF 1985 Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients. Arch Intern Med 145: 505-508
2. Barton CH, Vaziri ND, Martin DC, Choi S, Atikhani S 1987 Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine. Am J Med 83: 693-699
3. Boer WH, Fransen R, Shirley DG, Walter SJ, Boer P, Koomans HA 1995 Evaluation of the lithium clearance method: Direct analysis of tubular lithium handling by micropuncture. Kidney Int 47: 1023-1030
4. Chapman JR, Hording NGL, Griffiths D, Morris PJ 1985 Reversibility of cyclosporin nephrotoxicity after three months' treatment. Lancet 1: 128-129
5. Conte G, Dal Canton A, Sabbatini M, Napodano P, De Nicola L, Gigliotti G, Fuiana G, Testa A, Esposito C, Russo D, Andreucci VE 1989 Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects. Kidney Int 36: 1086-1092
6. Curtis JJ, Luke KG, Dubovsky E, Diethelm AG, Whelchel JD, Jones P 1986 Cyclosporin in therapeutic doses increases renal allograft vascular resistance. Lancet 2: 477-479
7. Dieperink H, Leyssac PP, Kemp E, Starklint H, Frandsen NE, Tvede N, Moller J, Buchler-Frederiksen P, Rossing N 1987 Nephrotoxicity of cyclosporin A in humans: effects on glomerular filtration and tubular reabsorption rates, Eur J Clin Invest 17: 493-196
8. Hoitsma AJ, Wetzels JF, van Lier HJ, Berden JH, Koene RA 1987 Cyclosporin treatment with conversion after three months versus conventional immunosuppression in renal allograft recipients. Lancet 1: 584-586
9. June CH, Thompson CB, Kennedy MS, Nims J, Thomas ED 1985 Profound hypomagnesemia and renal magnesium wasting associated with the use of cyclosporine for marrow transplantation. Transplantation 39: 620-624
10. Krusell LR, Jespersen LT, Christensen CK, Thomsen K, Pedersen OL 1987 Acute natriuresis induced by inhibition of proximal tubular reabsorption of sodium and water in hypertensives following acute calcium entry blockade with nifedipine. J Cardiovasc Pharmacol 10 (Suppl 10): S162-S163
11. Lin H-Y, Rocher LL, McQuillan MA, Schmaltz S, Palella TD, Fox IH 1989 Cyclosporine-induced hyperuricemia and gout. N Engl J Med 321: 287-292
12. Noordzij TC, Leunissen KM, Van Hooff JP 1991 Renal handling of urate and the incidence of gouty arthritis during cyclosporine and diuretic use. Transplantation 52: 64-67
13. Propper DJ, Whiting PH, Mackay J, Catto GRD 1990 Glomerulotubular function in long-term renal allograft recipients. A comparison of conventional therapy with cyclosporine. Transplantation 50: 72-75
14. Sabbatini M, De Nicola L, Sansone G, Conte G 1993 Renal hypoperfusion as the primary cause of cyclosporin-induced nephropathy. Nephrol Dial Transplant 8: 794-797
15. Scoble JE, Freestone A, Varghese Z, Fernando ON, Sweny P, Moorhead JF 1990 Cyclosporin-induced renal magnesium leak in renal transplant patients. Nephrol Dial Transplant 5: 812-815
16. Thomsen K 1984 Lithium clearance: a new method for determining proximal and distal tubular reabsorption of sodium and water. Nephron 37: 217-223
17. Versluis DJ, Wenting GJ, Derkx FH, Schalekamp MA, Jeekel J, Weimar W 1987 Who should be converted from cyclosporine to conventional immunosuppression in kidney transplantation, and why. Transplantation 44: 387-389
18. Versluis DJ, Wenting GJ, Jeekel J, Weimar W 1988 The influence of cyclosporine A on proximal tubular function in renal allografts. Transplant Proc 20 (Suppl 3): 686-690
19. Vincent HH, Wenting GJ, Versluis DJ, Weimar W, Schalekamp MA 1988 Impaired fractional excretion of lithium: an early marker of cyclosporine-induced changes in renal hemodynamics. Transplant Proc 20: 681-685
20. Wetzels JF, Wiltink PG, Hoitsma AJ, Huysmans FT, Koene RA 1988 Diuretic and natriuretic effects of nifedipine in healthy persons. Br J Clin Pharmacol 25: 547-553
21. Zietse R, van Ierland-van Leeuwen ML, Derkx FHM, Jzermans JNM, Schalekamp MADH, Weimar W 1994 Glomerular barrier function following conversion from cyclosporine to azathioprine in renal transplant recipients. Am J Kidney Dis 24: 927-931